South Dakota Investment Council Sanofi Transaction History

South Dakota Investment Council

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$40.34 - $46.64 $366,287 - $423,491	-9,080 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$40.83 - $45.43 $55,528 - $61,784	-1,360 Reduced 13.03%	9,080 $402,000
Q1 2018 May 10, 2018	SELL	$38.98 - $45.76 $22,491 - $26,403	-577 Reduced 5.24%	10,440 $418,000
Q4 2017 Feb 09, 2018	SELL	$42.86 - $50.61 $112,721 - $133,104	-2,630 Reduced 19.27%	11,017 $474,000
Q3 2017 Nov 09, 2017	BUY	$47.04 - $50.34 $641,954 - $686,989	13,647	13,647 $679,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $118B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.